The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves
Abstract
BACE1 is a promising therapeutic and preventive target for Alzheimer's disease because it is essential for amyloid deposition. However, the recent demonstration of BACE1 in modulating developmental myelination in both peripheral and central nervous systems raises a concern of its effect on myelin maintenance or remyelination, and inhibition of these processes will potentially be detrimental to the BACE1 inhibitor users who are susceptible to myelination diseases such as adult peripheral nerve injury or multiple sclerosis. In this report, we investigated the role of BACE1 during peripheral nerve remyelination in wildtype (WT) and BACE1‐null mice. We show here that genetic deletion of BACE1 affects sciatic nerve remyelination. The impaired remyelination appears to stem from the loss of neuregulin‐1 cleavage by BACE1. To demonstrate a direct cleavage of neuregulin‐1 by BACE1, we have identified a BACE1 cleavage site that turns out be highly conserved among neuregulin‐1 paralogues. Moreover, we show that neuregulin‐1 family member neuregulin‐3 is also cleavable by BACE1. We hypothesize that the BACE1‐cleaved extracellular domain of axonal neuregulin‐1, perhaps neuregulin‐3 as well, binds to Schwann cell ErbB receptors, which in turn regulate remyelination. Pharmacological inhibition of BACE1 should be carefully monitored to avoid alteration of signaling pathway that regulates remyelination.—Hu, X., He, W., Diaconu, C., Tang, X., Kidd, G. J., Macklin, W. B., Trapp, B. D., Yan, R. Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves. FASEB J. 22, 2970–2980 (2008)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
BACE1 knockout mice display reduced birth weight, hypomyelination, memory deficits, behavioral alterations, axon guidance impairment, impaired midbrain dopaminergic signaling, seizures, and abnormal electroencephalograms.
“Conversely, BACE1 knockout mice display reduced birth weight, hypomyelination, memory deficits, behavioral alterations, axon guidance impairment, impaired midbrain dopaminergic signaling, seizures, and abnormal electroencephalograms (EEGs).”
From BACE1: More than just a β‐secretase (2022) · cites this paper as [42]
Citations
Cites
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
The bHLH Transcription Factors OLIG2 and OLIG1 Couple Neuronal and Glial Subtype Specification
Zhou, Q., & Anderson, D. J. (2002) · Cell · doi:10.1016/s0092-8674(02)00677-3 · Cited by 1,059
Control of Peripheral Nerve Myelination by the ß-Secretase BACE1
Willem, M., Garratt, A. N., Novak, B., Citron, M., Kaufmann, S., Rittger, A., DeStrooper, B., Saftig, P., Birchmeier, C., & Haass, C. (2006) · Science · doi:10.1126/science.1132341 · Cited by 703
γ-Secretase, notch, Aβ and alzheimer's disease: Where do the presenilins fit in?
Sisodia, S. S., & St George-Hyslop, P. H. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn785 · Cited by 512
bHLH Transcription Factor Olig1 Is Required to Repair Demyelinated Lesions in the CNS
Arnett, H. A., Fancy, S. P. J., Alberta, J. A., Zhao, C., Plant, S. R., Kaing, S., Raine, C. S., Rowitch, D. H., Franklin, R. J. M., & Stiles, C. D. (2004) · Science · doi:10.1126/science.1103709 · Cited by 416
McConlogue, L., Buttini, M., Anderson, J. P., Brigham, E. F., Chen, K. S., Freedman, S. B., Games, D., Johnson-Wood, K., Lee, M., Zeller, M., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611687200 · Cited by 300 · cited 1×
“dramatic effects on amyloid deposition (11).”
β-Secretase Activity Increases with Aging in Human, Monkey, and Mouse Brain
Fukumoto, H., Rosene, D. L., Moss, M. B., Raju, S., Hyman, B. T., & Irizarry, M. C. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63159-8 · Cited by 294
Flagged first, then by citations
Research works printed but not linked: 44
- 10.1038/990107 · DOI · Paper page
- 10.1006/mcne.1999.0811 · DOI · Paper page
- 10.1038/990114 · DOI · Paper page
- 10.1001/archneur.62.2.192 · DOI
- 10.1038/nm0103-3 · DOI · Paper page
- 10.1038/85064 · DOI
- 10.1038/85059 · DOI · Paper page
- 10.1093/hmg/10.12.1317 · DOI · Paper page
- 10.1111/j.1471-4159.2004.02452.x · DOI
- 10.1038/nn1531 · DOI
- 10.1074/jbc.M309219200 · DOI
- 10.1038/nn1797 · DOI · Paper page
- 10.1016/S0092-8674(02)00678-5 · DOI
- 10.1016/S0960-9822(02)00926-0 · DOI
- 10.1523/JNEUROSCI.4717-05.2006 · DOI
- 10.1073/pnas.95.9.5269 · DOI
- 10.1016/S0304-3940(02)01387-3 · DOI
- 10.1006/exnr.1993.1091 · DOI
- 10.1083/jcb.146.5.1173 · DOI
- 10.1074/jbc.M104350200 · DOI
- 10.1083/jcb.200509174 · DOI
- 10.1126/science.1095862 · DOI
- 10.1038/nm1088 · DOI
- 10.1001/archneur.1968.00480060068009 · DOI
- 10.1016/0006-8993(72)90215-6 · DOI
- 10.1016/j.neuron.2005.08.017 · DOI
- 10.1016/j.conb.2006.08.008 · DOI
- 10.1126/stke.3252006pe11 · DOI
- 10.1523/JNEUROSCI.17-05-01642.1997 · DOI
- 10.1523/JNEUROSCI.3785-05.2006 · DOI
- 10.1002/jnr.490260308 · DOI
- 10.1111/j.1471-4159.1992.tb10966.x · DOI
- 10.1016/j.bmcl.2003.11.061 · DOI
- 10.1016/j.ab.2005.04.019 · DOI
- 10.1111/j.1471-4159.2004.02719.x · DOI
- 10.1046/j.1471-4159.2003.01597.x · DOI
- 10.1021/bi025926t · DOI
- 10.1083/jcb.12.2.361 · DOI
- 10.1146/annurev.ne.13.030190.000355 · DOI
- 10.1073/pnas.94.18.9562 · DOI
- 10.1242/jcs.02799 · DOI
- 10.1083/jcb.152.6.1289 · DOI
- 10.1002/cne.901930310 · DOI
- 10.1523/JNEUROSCI.15-06-04488.1995 · DOI
Cited by
Sorted by citations
Alzheimer's disease as homeostatic responses to age-related myelin breakdown
Bartzokis, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.08.007 · Cited by 546
Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process
De Strooper, B. (2010) · Physiological Reviews · doi:10.1152/physrev.00023.2009 · Cited by 455
Animal Models of Alzheimer Disease
LaFerla, F. M., & Green, K. N. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006320 · Cited by 419
Kandalepas, P. C., Sadleir, K. R., Eimer, W. A., Zhao, J., Nicholson, D. A., & Vassar, R. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1152-3 · Cited by 240
Soluble amyloid precursor protein-α modulates β-secretase activity and amyloid-β generation
Obregon, D., Hou, H., Deng, J., Giunta, B., Tian, J., Darlington, D., Shahaduzzaman, M., Zhu, Y., Mori, T., Mattson, M. P., et al. (2012) · Nature Communications · doi:10.1038/ncomms1781 · Cited by 192
BACE1 Deficiency Causes Altered Neuronal Activity and Neurodegeneration
Hu, X., Zhou, X., He, W., Yang, J., Xiong, W., Wong, P., Wilson, C. G., & Yan, R. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1334-10.2010 · Cited by 162
Self-citationThe keystone of Alzheimer pathogenesis might be sought in Aβ physiology
Puzzo, D., Gulisano, W., Arancio, O., & Palmeri, A. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.039 · Cited by 116
BACE1: More than just a β‐secretase
Taylor, H. A., Przemylska, L., Clavane, E. M., & Meakin, P. J. (2022) · Obesity Reviews · doi:10.1111/obr.13430 · Cited by 107
Hitt, B. D., Jaramillo, T. C., Chetkovich, D. M., & Vassar, R. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-31 · Cited by 99
APPswe/Aβ regulation of osteoclast activation and RAGE expression in an age-dependent manner
Cui, S., Xiong, F., Hong, Y., Jung, J.-U., Li, X.-S., Liu, J.-Z., Yan, R., Mei, L., Feng, X., & Xiong, W.-C. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.299 · Cited by 101
“Human Ab (1-42) (from AnaSpec, Fremont, CA, USA) was used.”
MethodSelf-citationAl-Tel, T. H., Semreen, M. H., Al-Qawasmeh, R. A., Schmidt, M. F., El-Awadi, R., Ardah, M., Zaarour, R., Rao, S. N., & El-Agnaf, O. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201181f · Cited by 53
Oligodendrocytes are a Novel Source of Amyloid Peptide Generation
Skaper, S. D., Evans, N. A., Soden, P. E., Rosin, C., Facci, L., & Richardson, J. C. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0022-9 · Cited by 43
Inhibition of amyloid precursor protein secretases reduces recovery after spinal cord injury
Pajoohesh-Ganji, A., Burns, M. P., Pal-Ghosh, S., Tadvalkar, G., Hokenbury, N. G., Stepp, M. A., & Faden, A. I. (2014) · Brain Research · doi:10.1016/j.brainres.2014.02.049 · Cited by 29
Metadata
- Authors
- Hu, X., He, W., Diaconu, C., Tang, X., Kidd, G. J., Macklin, W. B., Trapp, B. D., & Yan, R.
- Affiliations
- Department of Neurosciences Lerner Research Institute, Cleveland Clinic Foundation Cleveland Ohio USA
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2008-04-15
- Volume
- 22
- Issue
- 8
- Pages
- 2970-2980
- ISSN
- 0892-6638
- 1530-6860
- Cited by
- 155
- References
- 7
- Language
- en
- Funders
- National Institutes of Health (AG025493)
- National Multiple Sclerosis Society
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review